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6. G.P. MURPHY, New York, Alan R. Liss, Inc.,
374 pp, 1983, £58.
Unlike most book series of this genre, the
readership would appear at first to be readily
identified as specialists claiming to be surgical
oncologists; but in this country it is still arguable
whether such a specialty exists in its own right.
(The controversy as to whether Britain is in fact 40
years behind the United States of America in the
field of surgical oncology is currently being debated
within the columns of the British Medical Journal).
This volume highlights the dilemma. Of the dozen
or so chapters, two would appeal to the head and
neck surgeons, two to the gynaecologists, two to
the general surgeons, one to the thoracic surgeons
and one to the urologists. Does an individual
surgeon in this country deal with cancer of the
head and neck, cancer of the cervix and broncho-
genic cancer as well as dealing with the gastro-
intestinal malignancies? If not, there is no
appropriate readership for this book.
My other major criticism is the solipsist view of
the subject, characteristic of American volumes,
which goes beyond the simple avoidance of
citations of European contributions to oncology in
expressing a peculiarly American attitude to a
number of the subjects covered. For example, cyto-
reductive surgery for various advanced cancers has
theoretical attractions so far untested scientifically,
and yet is expressed as an article of faith in a
number of areas of this book. The chapter by
Letton, entitled "Improved Survival by Routine
Screening for Breast Cancer", is again quite extra-
ordinary in its North American uncritical
acceptance of routine screening. The author starts
out with the extraordinary dogmatic statement, that
as the mortality from breast cancer is static in the
United States of America and the incidence of the
disease is increasing, therefore more women are
being cured than previously, completely ignoring
the fact that as yet no therapeutic trial has demon-
strated improved survival with one treatment
compared with another. By concentrating on the
experience of the uncontrolled study entitled Breast
Cancer Demonstration and Detection Project
(BCDDP), the subject becomes very confusing and
yet the author, having convinced himself that
screening saves lives, then agrees that the national
programme is too expensive and screening should
be restricted to high risk groups only. Included
amongst the high risk groups are those women who
intuitively believe they will develop breast cancer!
Yet there is absolutely no evidence forthcoming
that screening of high risk groups only will save
lives.
The chapter I found particularly interesting was
by Takita, reviewing the evidence in favour of
specific and non-specific immunotherapy after
potentially curative resection of squamous cell
carcinoma of the lung. The evidence produced that
immunotherapy does improve survival for this
lethal disease is rather convincing, yet if this is the
case, why is such therapy not freely used in this
country? Either there is something wrong with the
evidence that I have been unable to pick up or the
Atlantic Divide has for once inhibited the trans-
location of a useful therapeutic advance.
At £58 I think this book is of far too little use to
be recommended for surgeons with an interest in
cancer, particularly as all relevant sections will have
been covered by reading the original papers in the
specialist journals where they first appeared. For
example, the one British contribution by Keighley
et al. on Techniques for bowel preparation prior to
colonic resection will surely have been read by all
British gastroenterology surgeons in the pages of
the British Journal of Surgery.
In conclusion, therefore, yet another profit-
making title for the publishers and an expensive
addition for libraries at a time of economic
recession, of little value for practising surgeons.
M. Baum
Dept. Surgery,
Kings College Hospital Medical School,
London.
Beneficial Effects of Endotoxins. ALOIS NOWOTNY,
USA, Plenum Press, xiii + 581 pp, 1983, £69.50.
A. Nowotny, a major contributor to the field, has
put together a most valuable monograph. While
multi-authored, it covers the field clearly,
authoratively and comprehensively because of
effective editing. The effects of endotoxin on non-
specific resistance to infection, on blood clotting,
on antibody production and cell mediated
immunity and on the release of lymphokines,
including interferon, are described. This multiplicity
of biological effects evoked by endotoxin makes it
unlikely that there is a simple mechanism
responsible for its anti-tumour activity and its effect
on the radiosensitivity of mammals. For the whole
of the century, cancer researchers have been
fascinated by the occasional, spectacular regression
of large tumour masses, first observed in man by542 BOOK REVIEWS
Coley and replicated in animal models, including
primary as well as transplanted tumours, by
Andervant, who showed that an important
component of this effect was the destruction of the
blood supply of the tumours by haemorrhagic
necrosis. That this effect on newly formed blood
vessels is not the only mechanism by which
endotoxin can affect the growth of malignant cells
is clearly shown by its action on ascitic cancers and
leukaemias. This diversity of anti-tumour activities
of endotoxin makes it obligatory to consider an
involvement of endotoxins when a natural product
produces an anti-tumour action and especially if it
causes the rapid regression of large tumour masses.
Endotoxin activity can be introduced accidentally in
a large variety of ways, even when procedures are
sterile; dead bacteria have endotoxin. For example,
the use of the bacterial product protein A to
concentrate immunoglobins introduces the risk of
endotoxin contamination.
This book should be read not only by workers
who are deliberately studying endotoxin, but by all
who are investigating the anti-tumour or immuno
modulating effects of proteins and products derived
from micro-organisms.
P. Alexander,
CRC Department of Medical Oncology,
University of Southampton.
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